319 related articles for article (PubMed ID: 32665166)
1. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [
Tsutani Y; Nakayama H; Ito H; Handa Y; Mimae T; Miyata Y; Okada M
Clin Lung Cancer; 2021 May; 22(3):e431-e437. PubMed ID: 32665166
[TBL] [Abstract][Full Text] [Related]
2. Sublobar resection for lung adenocarcinoma meeting node-negative criteria on preoperative imaging.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Ann Thorac Surg; 2014 May; 97(5):1701-7. PubMed ID: 24679941
[TBL] [Abstract][Full Text] [Related]
3. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
4. Prediction of pathologic node-negative clinical stage IA lung adenocarcinoma for optimal candidates undergoing sublobar resection.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2012 Dec; 144(6):1365-71. PubMed ID: 22883546
[TBL] [Abstract][Full Text] [Related]
5. Glucose Uptake Values in Positron Emission Tomography Are Useful to Predict Survival after Sublobar Resection for Lung Cancer.
Nakamura H; Saji H; Marushima H; Tagaya R; Kimura H; Takagi M
Thorac Cardiovasc Surg; 2017 Mar; 65(2):150-157. PubMed ID: 26909560
[No Abstract] [Full Text] [Related]
6. Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma.
Kagimoto A; Tsutani Y; Handa Y; Mimae T; Miyata Y; Okada M
Ann Surg Oncol; 2021 Apr; 28(4):2068-2075. PubMed ID: 32946014
[TBL] [Abstract][Full Text] [Related]
7. Appropriate sublobar resection choice for ground glass opacity-dominant clinical stage IA lung adenocarcinoma: wedge resection or segmentectomy.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Chest; 2014 Jan; 145(1):66-71. PubMed ID: 24551879
[TBL] [Abstract][Full Text] [Related]
8. Selection of sublobar resection for c-stage IA non-small cell lung cancer based on a combination of structural imaging by CT and functional imaging by FDG PET.
Yoshioka M; Ichiguchi O
Ann Thorac Cardiovasc Surg; 2009 Apr; 15(2):82-8. PubMed ID: 19471220
[TBL] [Abstract][Full Text] [Related]
9. Indications for sublobar resection of clinical stage IA radiologic pure-solid lung adenocarcinoma.
Hattori A; Matsunaga T; Takamochi K; Oh S; Suzuki K
J Thorac Cardiovasc Surg; 2017 Sep; 154(3):1100-1108. PubMed ID: 28629842
[TBL] [Abstract][Full Text] [Related]
10. Standardized Uptake Values in the Primary Lesions of Non-Small-Cell Lung Cancer in FDG-PET/CT Can Predict Regional Lymph Node Metastases.
Nakamura H; Saji H; Marushima H; Kimura H; Tagaya R; Kurimoto N; Hoshikawa M; Takagi M
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1388-93. PubMed ID: 25900205
[TBL] [Abstract][Full Text] [Related]
11. Outcomes and predictive factors for pathological node-positive in radiographically pure-solid, small-sized lung adenocarcinoma.
Kayata H; Isaka M; Terada Y; Mizuno K; Yasuura Y; Kojima H; Ohde Y
Gen Thorac Cardiovasc Surg; 2019 Jun; 67(6):544-550. PubMed ID: 30627979
[TBL] [Abstract][Full Text] [Related]
12. Occult mediastinal lymph node metastasis in FDG-PET/CT node-negative lung adenocarcinoma patients: Risk factors and histopathological study.
Miao H; Shaolei L; Nan L; Yumei L; Shanyuan Z; Fangliang L; Yue Y
Thorac Cancer; 2019 Jun; 10(6):1453-1460. PubMed ID: 31127706
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.
Furumoto H; Shimada Y; Imai K; Maehara S; Maeda J; Hagiwara M; Okano T; Masuno R; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Lung Cancer; 2018 Jul; 121():91-96. PubMed ID: 29858033
[TBL] [Abstract][Full Text] [Related]
14. Long-Term Results for Clinical Stage IA Lung Cancer: Comparing Lobectomy and Sublobar Resection.
Subramanian M; McMurry T; Meyers BF; Puri V; Kozower BD
Ann Thorac Surg; 2018 Aug; 106(2):375-381. PubMed ID: 29580779
[TBL] [Abstract][Full Text] [Related]
15. Segmentectomy for clinical stage IA lung adenocarcinoma showing solid dominance on radiology.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
Eur J Cardiothorac Surg; 2014 Oct; 46(4):637-42. PubMed ID: 24477740
[TBL] [Abstract][Full Text] [Related]
16. Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography.
Kagimoto A; Tsutani Y; Mimae T; Miyata Y; Okada M
Eur J Cardiothorac Surg; 2022 Jan; 61(2):279-286. PubMed ID: 34647128
[TBL] [Abstract][Full Text] [Related]
17. Maximum Standardized Uptake Value on Positron Emission Tomography is Associated With More Advanced Disease and High-risk Features in Lung Adenocarcinoma.
Koike T; Sato N; Hosoda Y; Tazawa M; Goto T; Sato S; Yamazaki M; Toyabe SI; Tsuchida M
Semin Thorac Cardiovasc Surg; 2022; 34(3):1051-1060. PubMed ID: 34320398
[No Abstract] [Full Text] [Related]
18. Surgeons' preference sublobar resection for stage I NSCLC less than 3 cm.
Huang CS; Hsu PK; Chen CK; Yeh YC; Hsu HS; Shih CC; Huang BS
Thorac Cancer; 2020 Apr; 11(4):907-917. PubMed ID: 32037690
[TBL] [Abstract][Full Text] [Related]
19. Sublobar resection versus lobectomy in patients aged ≤35 years with stage IA non-small cell lung cancer: a SEER database analysis.
Gu C; Wang R; Pan X; Huang Q; Zhang Y; Yang J; Shi J
J Cancer Res Clin Oncol; 2017 Nov; 143(11):2375-2382. PubMed ID: 28819775
[TBL] [Abstract][Full Text] [Related]
20. Prediction of Lymph Node Metastasis Using Semiquantitative Evaluation of PET for Lung Adenocarcinoma.
Kagimoto A; Tsutani Y; Izaki Y; Handa Y; Mimae T; Miyata Y; Okada M
Ann Thorac Surg; 2020 Sep; 110(3):1036-1042. PubMed ID: 32302663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
